CNMD - CONMED Corp Stock Price, Fair Value and News

$70.75-1.00 (-1.39%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

CNMD Price Action

Last 7 days

-6.5%

Last 30 days

10.8%

Last 90 days

3.8%

Trailing 12 Months

-34.6%

CNMD RSI Chart

CNMD Valuation

Market Cap

2.2B

Price/Earnings (Trailing)

16.59

Price/Sales (Trailing)

1.7

EV/EBITDA

14.39

Price/Free Cashflow

13.16

CNMD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

CNMD Fundamentals

CNMD Revenue

Revenue (TTM)

1.3B

Rev. Growth (Yr)

3.98%

Rev. Growth (Qtr)

-4.64%

CNMD Earnings

Earnings (TTM)

131.7M

Earnings Growth (Yr)

209.3%

Earnings Growth (Qtr)

63.41%

CNMD Profitability

EBT Margin

12.43%

Return on Equity

14.12%

Return on Assets

5.69%

Free Cashflow Yield

7.6%

CNMD Investor Care

Dividend Yield

1.13%

Dividend/Share (TTM)

0.8

Shares Dilution (1Y)

0.45%

Diluted EPS (TTM)

4.21

CNMD Alerts

Big jump in Earnings (Y/Y)

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.3B	1.3B	1.3B	0
2023	1.1B	1.1B	1.2B	1.2B
2022	1.0B	1.0B	1.1B	1.0B
2021	881.1M	978.5M	989.5M	1.0B
2020	950.7M	870.3M	874.5M	862.5M
2019	875.9M	901.4M	932.7M	955.1M
2018	811.9M	827.6M	839.7M	859.6M
2017	768.9M	772.6M	777.9M	796.4M
2016	722.4M	734.8M	750.4M	763.5M
2015	736.1M	728.9M	723.2M	719.2M
2014	757.6M	752.8M	748.5M	740.1M
2013	759.8M	763.1M	760.5M	762.7M
2012	735.9M	742.4M	751.5M	767.1M
2011	720.8M	723.0M	723.6M	725.1M
2010	699.5M	704.2M	709.0M	713.7M
2009	0	0	0	694.7M

Get all data in R, Python etc through our Historical Stock Data APIs

About CONMED Corp

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

CEO	Mr. Curt R. Hartman
WEBSITE	conmed.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	4100

CONMED Corp Frequently Asked Questions

What is the ticker symbol for CONMED Corp? What does CNMD stand for in stocks?

CNMD is the stock ticker symbol of CONMED Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of CONMED Corp (CNMD)?

As of Wed Nov 20 2024, market cap of CONMED Corp is 2.19 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CNMD stock?

You can check CNMD's fair value in chart for subscribers.

Is CONMED Corp a good stock to buy?

The fair value guage provides a quick view whether CNMD is over valued or under valued. Whether CONMED Corp is cheap or expensive depends on the assumptions which impact CONMED Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CNMD.

What is CONMED Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Nov 20 2024, CNMD's PE ratio (Price to Earnings) is 16.59 and Price to Sales (PS) ratio is 1.7. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CNMD PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on CONMED Corp's stock?

In the past 10 years, CONMED Corp has provided 0.054 (multiply by 100 for percentage) rate of return.